High affinity human antibodies to PCSK9

Details for Australian Patent Application No. 2009333326 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Sleeman, Mark W.; Martin, Joel H.; Huang, Tammy T.; MacDonald, Douglas

Agent Watermark

Pub. Number AU-A-2009333326

PCT Pub. Number WO2010/077854

Priority 61/218,136 18.06.09 US; 61/249,135 06.10.09 US; 61/210,566 18.03.09 US; 61/261,776 17.11.09 US; 61/168,753 13.04.09 US; 61/122,482 15.12.08 US

Filing date 15 December 2009

Wipo publication date 8 July 2010

International Classifications

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/077854 Priority application(s): WO2010/077854

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009333333-Inhibitors of diacylglycerol aclytransferase

2009333325-Monoand di-peg IL-10 production; and uses